Histogen Inc.|4May 28, 7:50 PM ET

Crean David Hugh 4

4 · Histogen Inc. · Filed May 28, 2020

Form 4

Period: 2020-05-26

Director

Transactions

Other
Stock Option (right to buy)
2017-05-22+17,210→ 17,210 total
Exercise: $3.70Exp: 2027-05-22→ Common Stock (17,210 underlying)
Other
Stock Option (right to buy)
2018-05-02+35,855→ 35,855 total
Exercise: $3.84Exp: 2028-05-02→ Common Stock (35,855 underlying)
Other
Stock Option (right to buy)
2017-10-25+4,302→ 4,302 total
Exercise: $3.84Exp: 2027-10-25→ Common Stock (4,302 underlying)

Footnotes (3)

[F1]Shares of common stock of the corporation formerly known as Histogen Inc. ("Histogen") were converted into shares of common stock of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of January 28, 2020, by and among the Issuer, Chinook Merger Sub, Inc. and Histogen (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of Histogen common stock was exchanged for 1.4342 shares of the Issuer's common stock (the "Conversion"). Immediately following the merger, the Issuer changed its name to Histogen Inc. All share numbers reflect the one-for-ten reverse stock split (the "Reverse Split") effected by the Issuer immediately prior to the completion of the merger.
[F2]Fully vested. Shares subject to the option and the exercise price have been adjusted based upon the Conversion and Reverse Split.
[F3]25% of the shares subject to the option vested on 03/12/2018 and 1/48 of the shares subject to the option shall vest monthly thereafter. Shares subject to the option and the exercise price have been adjusted based upon the Conversion and Reverse Split.

Documents

1 file